Axial Spondyloarthritis. Doug White, Rheumatologist Waikato Hospital
|
|
- Geoffrey Moore
- 5 years ago
- Views:
Transcription
1 Axial Spondyloarthritis Doug White, Rheumatologist Waikato Hospital
2 Disclosures Presentations / Consulting Abbott Laboratories AbbVie MSD Novartis Roche Clinical Trials Abbott Laboratories AbbVie Actelion Ardea Bioscience Celgene Eli Lilly Galapagos Pfizer Roche Sanofi
3 None could define axial spondyloarthritis
4 When a patient presents with a history of low back pain and there are no abnormalities on the radiograph, I will refer this patient to the neurologist. It is very unlikely that I refer this patient to the rheumatologist. Provided that low back pain is the only symptom.
5 What is spondyloarthritis? Diagnostic criteria Epidemiology Mechanical vs inflammatory back pain Early detection Management
6 Psoriatic Arthritis Reactive Arthritis Undifferentiated Spondyloarthritis Spondyloarthritis Ankylosing Spondylitis Enthesitis Related Arthritis (JIA) Enteropathic Arthritis
7 Enthesitis - MRI
8 Inflammation to Ankylosis
9 Enthesitis: The Psoriatic Nail
10 Modified New York Criteria for AS Clinical Criteria Low back pain and stiffness for >3 months which improves with exercise and not with rest Limitation in spinal motion in frontal and saggital planes Limitation of chest expansion compared to norms for age and gender Radiographic criteria Radiographic sacroiliitis >Grade 2 bilaterally or >Grade 3-4 unilaterally AS confirmed if radiographic criterion and >1 clinical criterion met
11 Sacroiliitis on Plain Imaging and MRI
12 ASAS Axial Spondyloarthritis Criteria In patients with >3 months back pain and age <45 Sacroiliitis and >1 SpA feature OR HLA-B27 and >2 SpA features SpA Features Inflammatory back pain Psoriasis Anterior uveitis Inflammatory bowel disease HLA-B27 positive Dactylitis Enthesitis (heel) Good response to NSAIDs Family history of SpA Elevated CRP Sensitivity 89.2%, specificity 84.4%, n=649 Rudwaleit et al, Ann Rheum Dis, 2009
13 Spondyloarthritis: An Alternative Approach Spondyloarthritis Axial Spondyloarthritis (axspa) Peripheral Spondyloarthritis Non-radiographic axspa (nr-axspa) Radiographic axspa Clinical axspa
14 Progression from nr-axspa to AS
15 Parameter Non-radiographic axial SpA Radiographic axial SpA (AS) P Study Age, mean years NS GESPIC NS Herne Male sex, % <0.001 GESPIC <0.001 Herne <0.001 SCQM HLA-B27 positive, % NS GESPIC NS Herne NS SCQM Elevated CRP, % GESPIC <0.001 Herne <0.001 SCQM Total pain, NS GESPIC 4 5 NS Herne 6 6 NS SCQM Patient global assessment, NS GESPIC NS Herne 6 6 NS SCQM
16 Parameter Non-radiographic axial SpA Radiographic axial SpA (AS) P Study BASDAI, NS GESPIC NS Herne SCQM BASFI, GESPIC NS Herne NS SCQM BASMI, <0.001 GESPIC 1 2 <0.001 SCQM Inflammatory lesions in the spine on MRI, % Herne Treatment response to TNF antagonists* Non-radiographic Radiographic Parameter axial SpA axial SpA (AS) P Study ASAS40 response, % NS ESTHER NS RAPID-AxSpA NS SCQM ASAS partial remission, % NS ESTHER *TNF antagonists are not approved by Medsafe for the treatment of non-radiographic axial SpA in New Zealand
17 Cumulative Percentage Delay in diagnosis Age Average delay in diagnosis: 7 years
18 Implications In Argentina, 26% of those with AS are unemployed compared to 4.5% without In a Dutch study, withdrawal from work was 3x more likely if the person had AS Presenteeism Being at work but not performing well 77% say this was an issue for them
19 So, how can we pick up SpA earlier? Examination often unhelpful Lumbar side flexion first to change CRP can be normal in up to 40% Plain imaging is often normal early
20 So, how can we pick up SpA earlier? Inflammatory Back Pain is present in ~90% of axial SpA
21
22 IBP if 2/4 Inflammatory Back Pain: Criteria Calin et al Age <40 Duration >3 months Insidious onset Morning stiffness Improvement with exercise Sens 95% Spec 76% IBP if 4/5 Rudwaleit et al Morning stiffness >30mins Improved with exercise but not with rest Awakening in the 2 nd half of the night with pain Alternating buttock pain Sens 70.3% Spec 81.2% Expert opinion (ASAS) Age <40 Insidious onset Improvement with exercise No improvement with rest Pain at night Sens 79.6% Spec 72.4% IBP if 4/5
23 Screening for SpA in Chronic Back Pain Chronic Back Pain (>3 months) First symptom <45 years of age Inflammatory Back Pain If present then approx 1:5 has axial SpA Sacroiliitis on Imaging HLA-B27 +ve Approx 1:3 has axial SpA Refer to Rheumatologist Sieper, Ann Rheum Dis, 2005
24 Performance of Referral Guidelines Brandt, Ann Rheum Dis, 2007
25
26
27 Effect of 24 weeks Anti-TNF on productivity Median change in productivity score Median % change in productivity score Mean number of working days lost during study Placebo Infliximab P-value < % 62% < Van der Heidje, Arthritis Rheum, 2006
28 Effect on Work Productivity
29 ASAS 40 response to anti-tnf therapy No head-head comparison data available; data from phase III studies
30 Why Treat Ankylosing Spondylitis - Mortality Ann Rheum Dis 2011;70: doi: /ard
31
32 Response to NSAIDs AS (n-69) Mechanical Back Pain (n-768) 0 Etoricoxib (n-195) Placebo (n-93) Van der Heidje, Arthritis Rheum, 2005 Amor, Rev Rheum Eng Ed, 1995
33 Management of axial SpA
34 Conclusions Important cause of back pain in younger adults Associated with significant morbidity, mortality and work loss Diagnosis may be expedited by awareness of inflammatory back pain Several effective treatment options are available
35
SpA non-radiografica: fase precoce di spondilite anchilosante o altro?
Rheumatology Department of Lucania, S. Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera SpA non-radiografica: fase precoce di spondilite anchilosante o altro? Ignazio Olivieri Disclosures
More informationDr Tracey Kain. Associate Professor Ed Gane
Associate Professor Ed Gane New Zealand Liver Transplant Unit Auckland Dr Tracey Kain Consultant Rheumatologist Grace Orthopaedic Centre Tauranga Hospital Tauranga 7:00-7:55 Abbvie Breakfast Session 1.
More informationWhat is Axial Spondyloarthritis?
Physiotherapist Module 2 What is Axial Spondyloarthritis? How does it apply to physiotherapists? Claire Harris, Senior Physiotherapist, London North West Healthcare NHS Trust Susan Gurden, Advanced Physiotherapy
More informationAssessment of Inflammatory Back Pain: New Concepts in Diagnosis
Assessment of Inflammatory Back Pain: New Concepts in Diagnosis March 2 nd, 2018 Spine Therapy Network Interprofessional Synposium Sheraton Toronto Airport Hotel, Toronto, CANADA Laura Passalent PT, BScPT,
More informationwww.fisiokinesiterapia.biz Peak onset between 20 and 30 years Form of spondyloarthritis (cause inflammation around site of ligament insertion into bone) and association with HLA-B27 Prevalence as high
More information37 year old male with several year history of back pain
37 year old male with several year history of back pain Inflammatory Low Back Pain Clues onset before the age of 40 years insidious onset, chronic (>3 months) pain morning stiffness for longer than 30
More informationImaging of axial spondyloarthritis including ankylosing spondylitis
Imaging of axial spondyloarthritis including ankylosing spondylitis ACR 2012 Prof. Dr. med. J. Braun Rheumazentrum Ruhrgebiet, Herne Ruhr-Universität Bochum Germany Modified New York Criteria 1984 for
More informationAxial Spondyloarthritis: Issues & Controversies
Axial Spondyloarthritis: Issues & Controversies Atul Deodhar, MD Professor of Medicine Oregon Health & Science University Portland, OR WRA 2018 Annual Meeting, Leavenworth, WA. 16 th September, 2018 Disclosures:
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Health Technology Appraisal Secukinumab for treating ankylosing spondylitis after inadequate response to non-steroidal anti-inflammatory drugs
More information2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Online supplementary material
2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis Online supplementary material 1. Introduction A systematic literature review (SLR) was performed to inform the
More informationDo HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation
Do HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging? Results from the DESIR cohort of patients with recent onset axial spondyloarthritis Ho Yin Chung
More informationThe Complex/Challenging Spine Patient Steve Wisniewski, M.D. Department of PM&R
The Complex/Challenging Spine Patient Steve Wisniewski, M.D. Department of PM&R 2011 MFMER slide-1 Disclosures None 2011 MFMER slide-2 Learning Objectives Review indications for obtaining imaging studies
More informationARTHRITIS ADVISORY COMMITTEE MEETING
ARTHRITIS ADVISORY COMMITTEE MEETING July 23, 2013 sbla 125057/323: adalimumab for the treatment of Active non-radiographic axial spondyloarthritis in adults with objective signs of inflammation by elevated
More informationConcept of Spondyloarthritis (SpA)
Concept of Spondyloarthritis (SpA) Spondyloarthritis: Characteristic Parameters Used for Diagnosis I Symptoms Inflammatory back pain Imaging Lab ESR/CRP Patient s history Good response to NSAIDs Spondyloarthritis-Characteristic
More informationJuvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA)
www.printo.it/pediatric-rheumatology/gb/intro Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA) Version of 2016 1. WHAT IS JUVENILE SPONDYLOARTHRITIS/ENTHESITIS- RELATED ARTHRITIS (SpA-ERA)
More informationARTHRITIS ADVISORY COMMITTEE MEETING
ARTHRITIS ADVISORY COMMITTEE MEETING July 23, 2013 sbla 125160/215: Cimzia (certolizumab) for the treatment of active axial spondyloarthritis, including patients with ankylosing spondylitis Disclaimer
More informationadalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott)
adalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott) 08 March 2013 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationChapter 2. Overview of ankylosing spondylitis
Chapter 2 Overview of ankylosing spondylitis The concept and classification of spondyloarthritis The term spondyloarthritis (SpA) comprises AS, reactive arthritis, arthritis/spondylitis associated with
More informationBRIEF REPORT. Denis Poddubnyy, 1 Hildrun Haibel, 1 J urgen Braun, 2 Martin Rudwaleit, 3 and Joachim Sieper 1
ARTHRITIS & RHEUMATOLOGY Vol. 67, No. 9, September 2015, pp 2369 2375 DOI 10.1002/art.39225 VC 2015, American College of Rheumatology BRIEF REPORT Clinical Course Over Two Years in Patients With Early
More informationNew developments in the diagnosis and treatment of axial spondyloarthritis
Review: Clinical Trial Outcomes New developments in the diagnosis and treatment of axial spondyloarthritis Clin. Invest. (2013) 3(2), 153 171 Spondyloarthritis (SpA) is an umbrella term for a group of
More informationABSTRACT Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis of axial spondyloarthritis
1 Rheumatology, Med Klinik I, Charité, Campus Benjamin Franklin, Berlin, Germany; 2 Leiden University Medical Center, Leiden, The Netherlands; 3 Maastricht University Medical Center, Maastricht, The Netherlands;
More informationEvaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort
To cite: Abawi O, van den Berg R, van der Heijde D, et al. Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort. RMD Open 2017;3:e000389.
More informationIdentification of Psoriatic Arthritis and Ankylosing Spondylitis Early Detection to Facilitate Appropriate Care
Identification of Psoriatic Arthritis and Ankylosing Spondylitis Early Detection to Facilitate Appropriate Care Joy Schechtman D.O. Professor Midwestern University 64C-1876207 Disclosures None 3 64C-1876207
More informationARD Online First, published on October 11, 2005 as /ard
ARD Online First, published on October 11, 2005 as 10.1136/ard.2005.044206 Combining information obtained from MRI and conventional radiographs in order to detect sacroiliitis in patients with recent-onset
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 23 April 2009 Doc. Ref. CPMP/EWP/4891/03 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON CLINICAL
More informationIntroduction. Natural Progression of AS. Sacroiliac Joint. Clinical Features and Assessment of Ankylosing Spondylitis
Clinical Features and Assessment of Ankylosing Spondylitis Dr. YIM, Cheuk Wan Specialist in Rheumatology United Christian Hospital Introduction Ankylo=fusion Spondylitis=inflammation of spine Affect 0.1-0.5%
More informationCLOSER LOOK AT SpA. Dr. Mohamed Bedaiwi. Consultant Rheumatologist Rheumatology Unit - KKUH
CLOSER LOOK AT SpA Dr. Mohamed Bedaiwi Consultant Rheumatologist Rheumatology Unit - KKUH Closer look at SpA I. Categories II. SIGN & SYMPTOMS III. X-RAY IV. MRI V. MANAGMENT Spondyloarthritis (SpA)
More informationGuideline on the Clinical Investigation of Medicinal Products for the Treatment of Axial Spondyloarthritis
12 October 2017 EMA/CPMP/EWP/4891/03 Rev.1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Axial Draft agreed by
More informationCurrent Concept of Spondyloarthritis: Special Emphasis on Early Referral and Diagnosis
DOI 10.1007/s11926-012-0274-2 SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR) Current Concept of Spondyloarthritis: Special Emphasis on Early Referral and Diagnosis Salih Ozgocmen & Muhammad Asim Khan
More information10/28/2013. Disclosure. Ustekinumab. IL-12, IL-23 and Ustekinumab. IL-23 in Facet Joints in Patients with AS
for the Treatment of Patients with Active Ankylosing Spondylitis: Results of a 28-Week, Prospective, Open-Label, Proof-of-Concept Study (TOPAS) Disclosure The study was supported by an unrestricted research
More informationAssessing the Signs, Symptoms, and Clinical Manifestations of Axial SpA
Physiotherapist Module 3 Assessing the Signs, Symptoms, and Clinical Manifestations of Axial SpA Enhance your patient examination skills Claire Harris, Senior Physiotherapist, London North West Healthcare
More informationImaging and intervention of sacroiliac joint. Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital
Imaging and intervention of sacroiliac joint Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital Introduction 15%-25% of low back pain is related to sacroiliac joint (SIJ) pain SIJ pain is
More informationNonradiographic axial spondyloarthritis: clinical and therapeutic relevance
Ghosh and Ruderman Arthritis Research & Therapy (2017) 19:286 DOI 10.1186/s13075-017-1493-8 REVIEW Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance Nilasha Ghosh and Eric M.
More information2004 Health Press Ltd.
... Ankylosing spondylitis Maxime Dougados MD Professor of Rheumatology Hôpital Cochin René Descartes University Paris, France Désirée van der Heijde MD PhD Professor of Rheumatology University Hospital
More informationHeel pain in spondyloarthritis: results of a cross-sectional study of 275 patients
Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients E. Koumakis, L. Gossec, M. Elhai, V. Burki, A. Durnez, I. Fabreguet, M. Meyer, J. Payet, F. Roure, S. Paternotte, M. Dougados
More informationGolimumab, compared to placebo, significantly improved symptoms in adults with active nonradiographic
golimumab 50mg/0.5mL solution for injection in pre-filled pen or syringe and 100mg/mL solution for injection in pre-filled pen (Simponi ) SMC No. (1124/16) Merck Sharp & Dohme Limited 8 January 2016 The
More informationT he spondyloarthritides (SpA) comprise five subtypes:
1305 EXTENDED REPORT Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept M Rudwaleit*, X
More informationNIH Public Access Author Manuscript Curr Opin Rheumatol. Author manuscript; available in PMC 2011 January 20.
NIH Public Access Author Manuscript Published in final edited form as: Curr Opin Rheumatol. 2010 September ; 22(5): 603 607. doi:10.1097/bor.0b013e32833c7255. Early axial spondyloarthritis Robert A Colbert
More informationDifferentiating Inflammatory and Mechanical Back Pain
This resource was organised and funded by AbbVie. It has been developed in collaboration with Claire Harris, Susan Gurden, Dr Jane Martindale, Claire Jeffries and NASS. For UK healthcare professionals
More informationAssessing the Signs, Symptoms, and Clinical Manifestations of Axial SpA
This resource was organised and funded by AbbVie. It has been developed in collaboration with Claire Harris, Susan Gurden, Dr Jane Martindale, Claire Jeffries and NASS. For UK healthcare professionals
More informationChapter 2 Criteria and Disease Activity Measures in Axial Spondyloarthropathies
Chapter 2 Criteria and Disease Activity Measures in Axial Spondyloarthropathies Jose Aliling 1 and Lawrence H Brent 1* Einstein Medical Center, USA * Corresponding Author: Lawrence H Brent, Einstein Medical
More informationFrequency of low bone mineral density in spondyloarthropathy presenting at a tertiary care hospital
973 ORIGINAL ARTICLE Frequency of low bone mineral density in spondyloarthropathy presenting at a tertiary care hospital Lubna Nazir, Shafique Rehman, Amir Riaz, Mohammad Saeed, Tahira Perveen Abstract
More informationESPONDILOARTROPATÍAS. Dr. Julio Ramírez García
ESPONDILOARTROPATÍAS Dr. Julio Ramírez García Bloque 1: Caracterización de los pacientes con SpA axial ABSTRACT NUMBER: 1509 Similarities and Differences between Non-Radiographic and Radiographic Axial
More informationCharacterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry
Arthritis Care & Research Vol. 70, No. 11, November 2018, pp 1661 1670 DOI 10.1002/acr.23534 2018, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College
More informationHello, I m Christopher Ritchlin, from the University of Rochester Medical Center, and I have the pleasure today of discussing with you abstracts
Hello, I m Christopher Ritchlin, from the University of Rochester Medical Center, and I have the pleasure today of discussing with you abstracts presented at the 2012 American College of Rheumatology meeting
More information6/6/2017. Spondyloarthritis and Osteopathic Primary Care: Facts and Challenges. Progression of Ankylosing Spondylitis Classic Disease
1 Outline Talk 1 Introduction of spondyloarthritis (SpA) Clinical case challenge The problem of low back pain (LBP) in primary care and in osteopathic primary care Talk 2 What is SpA today? How many people
More informationSystematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of
Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of Ankylosing Spondylitis Márta Péntek Márta Péntek Systematic review and analysis
More informationAre gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort
Ortolan et al. Arthritis Research & Therapy (2018) 20:218 https://doi.org/10.1186/s13075-018-1705-x RESEARCH ARTICLE Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data
More informationUpdate - Imaging of the Spondyloarthropathies. Spondyloarthropathies. Spondyloarthropathies
Update - Imaging of the Spondyloarthropathies Donald J. Flemming, M.D. Dept of Radiology Penn State Hershey Medical Center Spondyloarthropathies Family of inflammatory arthritides of synovium and entheses
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29572 holds various files of this Leiden University dissertation. Author: Berg, Rosaline van den Title: Spondyloarthritis : recognition, imaging, treatment
More informationSCIENTIFIC DISCUSSION
European Medicines Agency London, 20 September 2007 Product name: Remicade Procedure number: EMEA/H/C/240/II/95 SCIENTIFIC DISCUSSION 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20)
More informationClinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
EXTENDED REPORT Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study Walter P Maksymowych, 1 Maxime Dougados, 2 Désirée van
More informationLow Back Pain - Inflammatory and Mechanical pdf 5 th Oct 2016
Low Back Pain - Inflammatory and Mechanical pdf 5 th Oct 2016 --------- ---------- Link to last year s webinar on ANKYLOSING SPONDYLITIS https://attendee.gotowebinar.com/recording/915273432122794498 ------------------------------------------------------------------------------------------
More informationSpondyloarthritis: Practice. New Concepts in. Epidemiology and Clinical
New Concepts in Spondyloarthritis: Epidemiology and Clinical Practice Atul Deodhar MD Professor of Medicine Oregon Health & Science University Portland, OR Northwest Rheumatism Society, Seattle, April
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/43590 holds various files of this Leiden University dissertation Author: Machado, Pedro Title: Health and imaging outcomes in axial spondyloarthritis Issue
More informationORIGINAL ARTICLE. Ho Yin Chung & Chak Sing Lau & Ka Pik Wu & Woon Sing Wong & Mo Yin MOK
Clin Rheumatol (2011) 30:947 953 DOI 10.1007/s10067-011-1693-6 ORIGINAL ARTICLE Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy
More informationABSTRACT ORIGINAL RESEARCH. Laure Tant. Nadine Delmotte. Maria Van den Enden. Valerie Gangji. Herman Mielants
Rheumatol Ther (2017) 4:121 132 DOI 10.1007/s40744-016-0051-1 ORIGINAL RESEARCH High Prevalence of Undiagnosed Axial Spondyloarthritis in Patients with Chronic Low Back Pain Consulting Non-Rheumatologist
More informationGender differences in effectiveness of treatment in rheumatic diseases
Gender differences in effectiveness of treatment in rheumatic diseases Irene van der Horst-Bruinsma Associate Professor Rheumatology Center of Excellence of Axial Spondyloarthritis ARC/VU University Medical
More informationJane T Osterhaus 1* and Oana Purcaru 2
Osterhaus and Purcaru Arthritis Research & Therapy 2014, 16:R164 RESEARCH ARTICLE Open Access Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing
More informationAnja Weiß 1*, In-Ho Song 2, Hildrun Haibel 2, Joachim Listing 1 and Joachim Sieper 1,2
Weiß et al. Arthritis Research & Therapy 2014, 16:R35 RESEARCH ARTICLE Open Access Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long
More informationClinical and spinal radiographic outcome in axial spondyloarthritis Maas, Fiona
University of Groningen Clinical and spinal radiographic outcome in axial spondyloarthritis Maas, Fiona IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationSeronegative Spondyloarthropathies (SpA)
Seronegative Spondyloarthropathies (SpA) Objectives: Introduction SpA disease information Pathogenesis Clinical features Team Members: Ameera Niazi - Lulwah AlShiha - Qaiss Almuhaideb - Abdullah Hashem
More informationClinical Tools to Assess and Monitor Spondyloarthritis
Curr Rheumatol Rep (2015) 17: 47 DOI 10.1007/s11926-015-0522-3 SPONDYLOARTHRITIS (MA KHAN, SECTION EDITOR) Clinical Tools to Assess and Monitor Spondyloarthritis Robert Landewé 1,2 & Astrid van Tubergen
More information5/4/2018. Outcome Measures in Spondyloarthritis. Learning Objectives. Outcome Measures Clinical Outcome Assessments
Outcome Measures in Spondyloarthritis Marina N Magrey MD Associate Professor Case Western Reserve University School of Medicine at MetroHealth Medical Center Learning Objectives What are outcome measures
More informationSpondylarthropathies. Outline. Introduction. Spondylarthropathy other than AS. Mimickers of spondylarthropathy. Conclusions.
Spondylarthropathies Filip M. Vanhoenacker Johan Van Goethem General Hospital St-Maarten Duffel-Mechelen Universities of Antwerp and Ghent Outline Introduction Spondylarthropathy other than AS Mimickers
More informationFirst Presentation of Joint Pain
First Presentation of Joint Pain Andrew Harrison Rheumatologist Wellington Regional Rheumatology Unit, HVDHB Bowen Centre, Crofton Downs, Wellington Assoc. Prof. in Medicine, University of Otago Wellington
More informationDepartment of Radiology, Aarhus University Hospital, Aarhus, Denmark; 4. Key words MRI, sacroiliitis, ankylosing spondylitis, axial spondyloarthritis.
Gadolinium contrast-enhanced MRI sequence does not have an incremental value in the assessment of sacroiliitis in patients with early inflammatory back pain by using MRI in combination with pelvic radiographs:
More informationQuality indicators, guidelines and outcome measures in ankylosing spondylitis
Quality indicators, guidelines and outcome measures in ankylosing spondylitis J. Zochling, J. Braun Jane Zochling, MBBS, MMed (ClinEpi), PhD, Research Fellow, Menzies Research Institute, Hobart, Australia;
More informationAWMSG SECRETARIAT ASSESSMENT REPORT. Certolizumab pegol (Cimzia ) 200 mg solution for injection. Reference number: 1211 FULL SUBMISSION
AWMSG SECRETARIAT ASSESSMENT REPORT Certolizumab pegol (Cimzia ) 200 mg solution for injection Reference number: 1211 FULL SUBMISSION This report has been prepared by the All Wales Therapeutics and Toxicology
More informationA mong the inflammatory rheumatic diseases
659 REVIEW Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care J Sieper, M Rudwaleit... An earlier diagnosis of ankylosing spondylitis
More informationAnkylosing Spondylitis. DR. Milt Baker SEA Courses 2017
Ankylosing Spondylitis DR. Milt Baker SEA Courses 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or
More informationX. Baraliakos 1, A.J. Kivitz 2, A.A. Deodhar 3, J. Braun 1, J.C. Wei 4, E.M. Delicha 5, Z. Talloczy 6, B. Porter 6, for the MEASURE 1 study group
Long-term effects of interleukin-17a inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial X. Baraliakos 1, A.J.
More informationAd-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)
Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March 2011 (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the
More information8/29/2012. Outline Juvenile idiopathic arthritis. 1. Classification-ILAR. 1. Classification-clinical diagnosis. 1. JIA classification
Outline Juvenile idiopathic arthritis 1. Classification and symptoms (ILAR-International league of Associations for Rheumatology) 2. Imaging J. Herman Kan, M.D. Section chief, musculoskeletal imaging Edward
More informationCertolizumab pegol (Cimzia) for the treatment of ankylosing spondylitis second or third line
Certolizumab pegol (Cimzia) for the treatment of ankylosing spondylitis second or third line August 2011 This technology summary is based on information available at the time of research and a limited
More informationScottish Medicines Consortium
Scottish Medicines Consortium etanercept 25mg vial of powder for subcutaneous injection (Enbrel ) (No. 212/05) Wyeth New indication: severe active ankylosing spondylitis inadequately controlled by conventional
More informationProgression of Nonradiographic Axial Spondyloarthritis to Ankylosing Spondylitis
ARTHRITIS & RHEUMATOLOGY Vol. 68, No. 6, June 2016, pp 1415 1421 DOI 10.1002/art.39542 VC 2016, American College of Rheumatology Progression of Nonradiographic Axial Spondyloarthritis to Ankylosing Spondylitis
More informationGolimumab: a novel anti-tumor necrosis factor
Golimumab: a novel anti-tumor necrosis factor Rossini M, De Vita S, Ferri C, et al. Biol Ther. 2013. This slide deck represents the opinions of the authors, and not necessarily the opinions of the publisher
More informationDIFFERENTIATING INFLAMMATORY AND MECHANICAL BACK PAIN
DIFFERENTIATING INFLAMMATORY AND MECHANICAL BACK PAIN CHALLENGE YOUR DECISION MAKING Claire Harris, Senior Physiotherapist, The North West London Hospitals NHS Trust Susan Gurden, Advanced Physiotherapy
More informationI J Sørensen,15 R Valle-Oñate,16 U Weber,17 J Wei,18 J Sieper,1,19
See Editorial, pg 1 Additional data (supplementary table) are published online only. To view these fi les please visit the journal online (http://ard.bmj. com). 1 Department of Medicine, Charité University
More informationMultiple Technology Appraisal (MTA)
National Institute for Health and Care Excellence Multiple Technology Appraisal (MTA) TNF-alpha inhibitors for ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of ankylosing
More informationHierarchy of Impairment of Spinal Mobility Measures in Ankylosing Spondylitis: Twelve-Year Data
Arthritis Care & Research Vol. 67, No. 11, November 2015, pp 1571 1577 DOI 10.1002/acr.22614 VC 2015, American College of Rheumatology ORIGINAL ARTICLE Hierarchy of Impairment of Spinal Mobility Measures
More informationSronegative Spondyloarthropathies. Dr. M Jokar
Sronegative Spondyloarthropathies Dr. M Jokar 1 Definition The spondyloarthropathies are a group of disorders that share certain clinical features and an association with the HLA-B27 allele 2 Spondyloarthropathies
More informationAPPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY
APPLICANT (stamp sticker acceptable) Page 1 Fm SA1620 Etanercept INITIAL APPLICATION - juvenile idiopathic arthritis Applications only from a named specialist rheumatologist. Approvals valid f 6 months.
More informationPerspective CME CME. Therapeutics for the treatment of spondyloarthritis: what, when and whom. Éric Toussirot*1,2 & Fabrice Michel1
Therapeutics for the treatment of spondyloarthritis: what, when and whom The therapeutic management of ankylosing spondylitis (AS) and spondyloarthritis includes AIDs and biological therapies (TNFa antagonists),
More informationOverview of axial spondyloarthritis
Chapter 2 Overview of axial spondyloarthritis The concept and classification of spondyloarthritis The term spondyloarthritis (SpA) comprises ankylosing spondylitis (AS), reactive arthritis, arthritis/spondylitis
More informationImpact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Micheroli et al. Arthritis Research & Therapy (2017) 19:164 DOI 10.1186/s13075-017-1372-3 RESEARCH ARTICLE Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
More informationAnkylosing spondylitis functional and activity indices in clinical practice
Journal of Medicine and Life Vol. 7, Issue 1, JanuaryMarch 2014, pp.7883 Ankylosing spondylitis functional and activity indices in clinical practice Popescu C* **, Trandafir M*, Bădică AM*, Morar F*, Predeţeanu
More informationNavarro-Compán et al. Arthritis Research & Therapy (2015) 17:265 DOI /s y
Navarro-Compán et al. Arthritis Research & Therapy (2015) 17:265 DOI 10.1186/s13075-015-0779-y RESEARCH ARTICLE Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic
More informationVitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international study
Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international study S. Fernandes 1,2, A. Etcheto 1,3, D. van der Heijde 4, R. Landewé 5, F. van den Bosch 6, M. Dougados 1,3, A. Moltó
More informationAPPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY
APPLICANT (stamp sticker acceptable) Page 1 Fm SA1621 Adalimumab INITIAL APPLICATION - rheumatoid arthritis Applications only from a rheumatologist. Approvals valid f 6 months. The patient has had an initial
More informationJuvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA)
www.printo.it/pediatric-rheumatology/gb/intro Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA) Version of 2016 1. WHAT IS JUVENILE SPONDYLOARTHRITIS/ENTHESITIS- RELATED ARTHRITIS (SpA-ERA)
More informationAnti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort
de Winter et al. Arthritis Research & Therapy (2018) 20:38 https://doi.org/10.1186/s13075-018-1535-x RESEARCH ARTICLE Open Access Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis:
More informationRheumatology Subcommittee of PTAC Meeting held 7 October (minutes for web publishing)
Rheumatology Subcommittee of PTAC Meeting held 7 October 2014 (minutes for web publishing) Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology
More informationConcept of Spondyloarthritis (SpA)
Concept of Spondyloarthritis (SpA) Undifferentiated SpA Juvenile SpA Ankylosing Spondylitis Psoriatic Arthritis Arthritis associated with Ulcerative Colitis/ Crohn s Disease Reactive Arthritis Acute anterior
More informationTechnology Assessment Report commissioned by the NIHR HTA Programme on behalf of NICE Final protocol
Technology Assessment Report commissioned by the NIHR HTA Programme on behalf of NICE Final protocol 1. Title of the project TNF-alpha inhibitors for ankylosing spondylitis and axial spondyloarthritis
More informationSudan JMS Vol. 11, No.2. Jun
Vtáx exñéüà Mohammed MasaudRab 1, Mahmoud H. Milad 2 and Abdalla M. Gamal 3* ABSTRACT Background: Ankylosing spondylitis is a relatively common worldwide chronic inflammatory disease that usually affects
More informationSPARTAN NEWS. Greetings!
Volume 3 Issue 1 SPARTAN NEWS Greetings! I am looking forward to seeing you at our Annual Meeting in Cambridge, MA and encourage you to register for the meeting as soon as possible if you haven't had the
More informationvan der Heijde et al. Arthritis Research & Therapy (2018) 20:61 https://doi.org/ /s
van der Heijde et al. Arthritis Research & Therapy (2018) 20:61 https://doi.org/10.1186/s13075-018-1556-5 RESEARCH ARTICLE Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis
More information